**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 7697-37-2 |Nitric acid | 38 | 231-714-2 |
|----------------|--------------------------------------|----------|-----------|
| 34513-98-9 |Ruthenium(III) nitrosyl nitrate | | 252-068-8 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: C
Risk Phrases: 35
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Causes severe burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes.
Ingestion:
Get medical aid immediately. Do NOT induce vomiting. If conscious
and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Oxidizer. Greatly increases the burning rate of
combustible materials.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on
skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7697-37-2:
United Kingdom, WEL - TWA: 2 ppm TWA; 5.2 mg/m3 TWA
United Kingdom, WEL - STEL: 4 ppm STEL; 10 mg/m3 STEL
United States OSHA: 2 ppm TWA; 5 mg/m3 TWA
Belgium - TWA: 2 ppm VLE; 5.3 mg/m3 VLE
Belgium - STEL: 4 ppm VLE; 10 mg/m3 VLE
France - VME: 2 ppm VME; 5 mg/m3 VME
France - VLE: 4 ppm VLE; 10 mg/m3 VLE
Germany: 2 ppm TWA; 5.2 mg/m3 TWA
Japan: 2 ppm OEL; 5.2 mg/m3 OEL
Malaysia: 2 ppm TWA; 5.2 mg/m3 TWA
Netherlands: 0.5 ppm STEL; 1.3 mg/m3 STEL
Russia: 2 mg/m3 TWA
Spain: 2 ppm VLA-ED; 5.2 mg/m3 VLA-ED
Spain: 4 ppm VLA-EC; 10 mg/m3 VLA-EC
CAS# 34513-98-9:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: N4O10Ru
Molecular Weight: 317.09
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Organic materials, finely powdered metals.
Hazardous Decomposition Products:
Nitrogen oxides.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7697-37-2: QU5775000 QU5900000
CAS# 34513-98-9 unlisted.
LD50/LC50:
CAS# 7697-37-2: Inhalation, rat: LC50 = 260 mg/m3/30M; Inhalation,
rat: LC50 = 130 mg/m3/4H; Inhalation, rat: LC50 = 67 ppm(NO2)/4H.
CAS# 34513-98-9.
Carcinogenicity:
Nitric acid -
Not listed by ACGIH, IARC, or NTP.
Ruthenium(III) nitrosyl nitrate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: NITRIC ACID SOLUTION
Hazard Class: 8
UN Number: 2031
Packing Group: II
IMO
Shipping Name: NITRIC ACID SOLUTION
Hazard Class: 8
UN Number: 2031
Packing Group: II
RID/ADR
No information available.
USA RQ: CAS# 7697-37-2: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 35 Causes severe burns.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36 Wear suitable protective clothing.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 7697-37-2: 1
CAS# 34513-98-9: 2
Canada
CAS# 7697-37-2 is listed on Canada's DSL List.
CAS# 34513-98-9 is listed on Canada's NDSL List.
CAS# 7697-37-2 is listed on Canada's Ingredient Disclosure List.
CAS# 34513-98-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7697-37-2 is listed on the TSCA inventory.
CAS# 34513-98-9 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 1/16/2002 Revision #1 Date: 10/05/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Ruthenium(III) Nitrosyl Chloride Monohydrate
| 18902-42-6 |
|
Hexaammineruthenium(III) Chloride
| 14282-91-8 |
|
1,2-Bis(diphenylphosphino)ethane nickel(II) chloride
| 14647-23-5 |
|
Tris(hydroxymethyl)phosphine
| 2767-80-8 |
|
2-Ethoxybenzaldehyde, 97+%
| 613-69-4 |
|
Methyl 3-Amino-2-Pyrazinecarboxylate, 98%
| 16298-03-6 |
|
Guanidine Hydrochloride without Anticaking Agent, 98%
| 50-01-1 |
|
Bis(Cyclopentadienyl)Osmium
| 1273-81-0 |
|
Scandium(III) Trifluoromethanesulfonate
| 144026-79-9 |
|
Tetraammineplatinum(II) nitrate
| 20634-12-2 |
|
Hydrogen hexachloroplatinate(IV) hexahydrate
| 16941-12-1 |
|
(S)-(-)-alpha-Methoxy-alpha-(Trifluoruomethyl)Phenylacetic Acid
| 17257-71-5 |
|
1,1'-(Methylenedi-p-phenylene)bis[3-(2-hydroxyethyl)]urea
| 7747-61-7 |
|
1,1'-(Methylenedi-p-phenylene)bis[3-(3-hydroxypropyl)]urea
| 20006-61-5 |
|
4-Methyl-2-Oxopentanoic Acid, Sodium Salt
| 4502-00-5 |
|
Cyclohexyltriphenylphosphonium Bromide, 97%
| 7333-51-9 |
|
Benzyltrimethylammonium Bromide
| 5350-41-4 |
|
Dehydroacetic Acid Sodium Salt, 99%
| 4418-26-2 |
|
Tris(2,6-dimethoxyphenyl)phosphine
| 85417-41-0 |
|
1-[1-(4-Chlorophenyl)Cyclobutyl]-3-Methylisobutylamine Hydrochloride
| 84484-78-6 |
|
1-(4-Chlorophenyl)-1-Cyclobutanecarbonitrile
| 28049-61-8 |
|
1,4-Phenylenediacetic acid, 97%
| 7325-46-4 |
|
1-(4-Methoxyphenyl)-1-Cyclopentanecarbonitrile
| 1206-15-1 |
|
15-Hydroxypentadecanoic Acid
| 4617-33-8 |
|
1,1,1-Trifluoro-2-Phenylbuten-2-ol
| 134418-70-5 |
|
1,1,1-Trifluoro-2-Phenylbutyn-2-ol
| 99727-20-5 |
|
3-Hydroxybutyonitrile
| 4368-06-3 |
|
Diacetone-d-glucose, 98+%
| 582-52-5 |
|
3,4-Epoxy-2-phenyl-1,1,1-trifluoro-2-butanol, mixture of
| 351003-37-7 |
|
3-Aminophenylacetylene
| 54060-30-9 |
|
Sodium Pivalate Hydrate, 99%
| 143174-36-1 |
|
Lithium tetrachloropalladate(II) hydrate, 99%
| 15525-45-8 |
|
Chlorobenzene
| 108-90-7 |
|
6-Bromo-1-Hexene, 97%
| 2695-47-8 |
|
Tributyl Citrate, 97%
| 77-94-1 |
|
Potassium tert-butoxide, 20 wt.% solution in THF
| 109-99-9 |
|
L-tert-Leucine-Tert-Butylester Hydrochloride
| 0-01-1 |
|
4-Keto-4,5,6,7-tetrahydrothianaphthene
| 13414-95-4 |
|
6-Hydroxyquinoline, 98%
| 580-16-5 |
|
DL-1-Aminoindane-1-Carboxylic Acid Hydrate, 98%
| 0-01-1 |
|
Maleic anhydride
| 108-31-6 |
|
2-Methyl-5-Nitroaniline, 96%
| 99-55-8 |
|
Heptane, for HPLC (99% n-Heptane)
| 142-82-5 |
|
beta-Nicotinamide Adenine Dinucleotide, Sodium Salt
| 20111-18-6 |
|
1-Bromopentadecane
| 629-72-1 |
|
2-Chlorobenzothiazole, 99%
| 615-20-3 |
|
2-Methylresorcinol, 98%
| 608-25-3 |
|
Ruthenium(III) nitrosyl nitrate, in diluted Nitric acid
| 7697-37-2 |
|
Ciprofibrate
| 52214-84-3 |
|
1-(4-Methylphenyl)-2-methylpiperazine
| 35947-11-6 |
|
|